)
Samuel Bennett, MD, MBA
Associate Director – Search & Evaluation
Novo Nordisk
Samuel Bennett is a physician and business development professional with 12+ years of experience across pharmaceutical business development, R&D, biotech consulting, life science venture capital and clinical medicine. Within Global Business Development at Novo Nordisk, he focus on identifying and then acquiring/licensing novel cardiometabolic therapies and have led multiple complex transaction processes, including the due diligence and negotiation for the acquisition of Akero Therapeutics. Strong experience in leading cross-functional diligence, deal execution and biotech asset valuation, combined with deep scientific and clinical expertise.
Sessions
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}